The pandemic may eventually subside but health reporters will be writing about the impacts of COVID-19 well into the future, aided by researchers who are already gathering a bevy of data points to cite in those stories.
The COVID-19 patient's health was deteriorating quickly at a Michigan hospital, but he was having none of the doctor's diagnosis. Despite dangerously low oxygen levels, the unvaccinated man didn't think he was that sick and got so irate over a hospital policy forbidding his wife from being at his bedside that he threatened to walk out of the building.
Beginning in May, Liberia saw a troubling spike in cases of COVID-19, but lacking the sophisticated equipment and technical ability to test samples, scientists at the National Public Health Institute of Liberia (NPHIL) were unsure whether or not the crisis could be attributed to an emerging strain of the virus.
The forever war between America’s pharmaceutical industry and America’s public interest is approaching a climactic moment. At stake is whether Big Pharma and its allies will keep drug prices zooming upward, or whether the federal government can slow that rise by negotiating prices for some expensive drugs taken by Medicare beneficiaries.
A study of British patients with a long history of depression highlights how difficult it can be to stop medication, even for those who feel well enough to try.